The Wnt-dependent master regulator NKX1-2 controls mouse pre-implantation development
Stem Cell Reports · 2024
DOI: 10.1016/j.stemcr.2024.04.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2024. Verfasst von Shoma Nakagawa und 16 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, 08003 Barcelona, Spain. Hauptthemen laut MEDLINE: Embryonic Development, Gene Expression Regulation, Developmental, Homeodomain Proteins, Transcription Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NICHD NIH HHS, NIH HHS.
Abstract (Originalsprache)
Embryo size, specification, and homeostasis are regulated by a complex gene regulatory and signaling network. Here we used gene expression signatures of Wnt-activated mouse embryonic stem cell (mESC) clones to reverse engineer an mESC regulatory network. We identify NKX1-2 as a novel master regulator of preimplantation embryo development. We find that Nkx1-2 inhibition reduces nascent RNA synthesis, downregulates genes controlling ribosome biogenesis, RNA translation, and transport, and induces severe alteration of nucleolus structure, resulting in the exclusion of RNA polymerase I from nucleoli. In turn, NKX1-2 loss of function leads to chromosome missegregation in the 2- to 4-cell embryo stages, severe decrease in blastomere numbers, alterations of tight junctions (TJs), and impairment of microlumen coarsening. Overall, these changes impair the blastocoel expansion-collapse cycle and embryo cavitation, leading to altered lineage specification and developmental arrest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, 08003 Barcelona, Spain.
- Department of Systems Biology, Columbia University, New York, NY, USA.
- Department of Systems Biology, Columbia University, New York, NY, USA; DarwinHealth Inc, New York, NY, USA.
- Departments of Medicine, Genetics and Development, Urology, and Systems Biology, Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
- Center for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, 08003 Barcelona, Spain; Institute of Human Genetics, CNRS, Montpellier, France.
- Department of Systems Biology, Columbia University, New York, NY, USA; Departments of Medicine, Genetics and Development, Urology, and Systems Biology, Herbert Irving Comprehensive Cancer Center, Vagelos College of Phys…
Förderung
- NCI NIH HHS
- NICHD NIH HHS
- NIH HHS
Zitieren
APA
Nakagawa, S., Carnevali, D., Tan, X., Alvarez, M. J., Parfitt, D. E., Di Vicino, U., Arumugam, K., Shin, W., Aranda, S., Normanno, D., Sebastian-Perez, R., Cannatá, C., Cortes, P., Neguembor, M. V., Shen, M. M., Califano, A., & Cosma, M. P. (2024). The Wnt-dependent master regulator NKX1-2 controls mouse pre-implantation development. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2024.04.004
Vancouver
Nakagawa S, Carnevali D, Tan X, Alvarez MJ, Parfitt DE, Di Vicino U, et al. The Wnt-dependent master regulator NKX1-2 controls mouse pre-implantation development. Stem Cell Reports. 2024. doi:10.1016/j.stemcr.2024.04.004
BibTeX
@article{Nakagawa2024,
author = {Nakagawa, Shoma and Carnevali, Davide and Tan, Xiangtian and Alvarez, Mariano J and Parfitt, David-Emlyn and Di Vicino, Umberto and Arumugam, Karthik and Shin, William and Aranda, Sergi and Normanno, Davide and Sebastian-Perez, Ruben and Cannatá, Chiara and Cortes, Paola and Neguembor, Maria Victoria and Shen, Michael M and Califano, Andrea and Cosma, Maria Pia},
title = {The Wnt-dependent master regulator NKX1-2 controls mouse pre-implantation development},
journal = {Stem Cell Reports},
year = {2024},
doi = {10.1016/j.stemcr.2024.04.004}
}
EUVIMED